Novotech in expansion mode as CRO sector continues to grow at 15%

BioPacificVentures and Co-Investor Capital Partners invest in Novotech and back expansion plans Sydney, Australia, Orange County, CA – October 21, 2007 — Novotech, the largest Australian owned contract research organization (CRO) with offices on the US east and west coasts, is now in rapid expansion mode as the CRO sector fundamentals continue to strengthen with [...]

Novotech alerts Pharma and Biotechs at DIA 2007 to Australias new R&D tax break that applies to clinical trials

New Tax break comes into effect July 1, 2007 Atlanta, GA – July 1, 2007 — Novotech, the largest Australian owned contract research organization (CRO) with offices on the US east and west coasts, announced on the eve of DIA 2007 that the new tax breaks for research in Australia, which includes clinical trials, starts [...]

Updated checklist for CRO partnering and trials selection in Australasian region announced at BIO 2007

May 8, 2007 – Boston, MA — Novotech, the largest Australian owned contract research organization (CRO) with offices on the US east and west coasts, has released its updated “Clinical Trials Checklist” for CROs, biotech, pharma and even VCs, to assist in the often challenging task of selecting a clinical trials partner in the Australasian [...]